NOVO NORDISK

Novo Nordisk, a healthcare company with a leading position in haemostasis management, is strongly committed to supporting haemostasis research and education... Access to Insight, the Novo Nordisk Haemostasis Grants Awards Initiative, supports research and education in haemophilia and other bleeding disorders. The grants, awards and scholarships will support haemostasis research and training of physicians in the field of haemostasis/haemophilia clinical management.

Also known as: Access to Insight